DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 170 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,060 | +1556.2% | 23,710 | +424.3% | 0.00% | – |
| Q2 2023 | $64 | -8.6% | 4,522 | 0.0% | 0.00% | – |
| Q1 2023 | $70 | -5.4% | 4,522 | 0.0% | 0.00% | – |
| Q4 2022 | $74 | -99.9% | 4,522 | 0.0% | 0.00% | – |
| Q3 2022 | $84,000 | +42.4% | 4,522 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | +40.5% | 4,522 | 0.0% | 0.00% | – |
| Q1 2022 | $42,000 | -4.5% | 4,522 | 0.0% | 0.00% | – |
| Q4 2021 | $44,000 | -71.4% | 4,522 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $154,000 | -7.2% | 4,522 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $166,000 | -18.2% | 4,522 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $203,000 | -21.3% | 4,522 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $258,000 | +11.2% | 4,522 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $232,000 | -14.1% | 4,522 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $270,000 | +45.2% | 4,522 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $186,000 | – | 4,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |